Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

A patient developed a blister at the injection site after hepatitis C treatment.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Intralesional cidofovir might be a good alternative treatment.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

Lymphatic vessels and hair follicles interact and may influence hair growth.

SLE affects lungs and kidneys similarly due to immune complexes.

Tislelizumab can cause cutaneous lupus erythematosus.

Tumor cells in calcifying epithelioma of Malherbe resemble hair follicle cells.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Early diagnosis and strong corticosteroids are crucial for managing lymphocytic cicatricial alopecia.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Mycosis fungoides can have unusual symptoms and may be misdiagnosed, but specific cell markers might suggest a lower risk of worsening.

Immune system changes may contribute to female pattern hair loss.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

A new skin cancer can develop where shingles once occurred.